Jan 14, 2025 6:30 am EST Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
Jan 6, 2025 7:55 am EST NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 11, 2024 8:05 am EST NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
Dec 9, 2024 8:10 am EST NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
Nov 19, 2024 8:15 am EST NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Nov 8, 2024 7:00 am EST NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Oct 22, 2024 8:10 am EDT NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
